Depression is one of the most common diseases of psychiatrists in the world. One of the causes of depression is medical diseases such as diabetes. Depression is also one of the psychiatric disorders with symptoms such as decreased interest and energy, guilt, failure, distraction, problems in concentration, self-loathing, anorexia, thoughts of death and suicide, insomnia, or Disturbances and disturbances in functioning are identified. Diabetic patients may suffer from mood disorders, including depression, due to this disease. This study aimed to review depression in patients with diabetes. Suffering from depression, in addition to aggravating the symptoms of diabetes, causes self-destructive symptoms such as overeating, overdrinking, not taking medications, or committing suicide, which disrupts the diabetes treatment process. So far, many studies have been done on the prevalence of depression in diabetic patients, which has identified that the prevalence of depression in diabetic patients is much higher than that of normal people, as well as the prevalence of depression in some people, such as women and Hungarians. D. Widows or divorcees, those who have a genetic history of disease. They suffer from depression more than others. It is suggested that psychiatric examination and counseling be done on these patients, especially those patients who are more prone to depression.
1. Atalay M, Laaksonen DE. Diabetes, oxidative stress, and physical exercise. J Sports Sci Med. 2002;1(1):1-14.
2. Cin GT, Fenkci SM, Yiğit U, Lektemur Alpan A. Periodontal parameters and periodontitis severity in type 2 diabetes patients with chronic complications. Ann Dent Spec. 2022;10(4):61-7.
3. Malik M, Mahjabeen M, Rana S, Hussain A, Hashmi A. Quality of Life and Depression among Postmenopausal women in Pakistan. Arch Pharm Pract. 2021;12(3):28-32.
4. Hinkle JL, Cheever KH, Brunner and Suddarths, Textbook of Medical-Surgical Nursing. 10th edition, Williams & Wilkins; 2004. 1203-149 pp.
5. Alharbi SS. Diabetes Mellitus as a Risk Factor for Different Types of Cancers: A Systematic Review. Clin Cancer Investig J. 2022;11(4):19-24.
6. Ahmann AJ. Guideline and Performance Measures for Diabetes. Am J Manag Care. 2007;13:6-41.
7. Shetgaonkar KA, Suragimath G, Varma S, Zope S. Two Way Relationship between Diabetes and Periodontitis: A Cross-Sectional Survey of Knowledge, Awareness, and Attitude. Int J Pharm Res Allied Sci. 2022;11(2):1-7.
8. Samir D, Ouissam B, Anfal D. Antioxidant and Antidiabetic Effect of Biosynthesis Zinc Nanoparticles by Using Polyherbal Aqueous Extract in Wistar Rats. J Biochem Technol. 2022;13(1):72-80.
9. Baydas G, Sonkaya E, Tuzcu M, Yasar A, Donder E. Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats. Acta Pharmacol Sin. 2005;26(4):417-22.
10. Sharifi A, Alqahtani AS, Almousaedi IH, Almotadaris SF, Ojaym AA, Al Alnuayr MA, et al. The association between trauma and the occurrence of diabetes mellitus at the age of less than 40 years. Pharmacophore. 2022;13(2):107-4.
11. Leonard EE. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care. 2004;27(7):1751-3.
12. Anbar GH, AlShahrani SM, Al Thubyani MM, Almarghlani A. Oral hygiene status of Bell's palsy and diabetic patient: a 23-month implants follow-up case report. Ann Dent Spec. 2021;9(2):72-8.
13. Bashir T, Morrissey H, Ball P. Systematic Review of Psychological and Educational Interventions Used to Improving Adherence in Diabetes and Depression Patients. Arch Pharm Pract. 2021;12(3):1-11.
14. Kaplan HI, Sadock BJ. Synopsis of psychiatry. 8th ed. Baltimore: Williams and Wilkins; 1998. p. 808,525.
15. Moskalyova L, Rudyk S, Podplota S, Dolgova O, Litvynenko S, Kukharchuk N. Affinity of Women's Depression with Bulesis Self-Help Regulations in the Postpartum Period. Int J Pharm Res Allied Sci. 2021;10(2):55-61.
16. Koopmanschap M. Coping with Type II diabetes: The patient's perspective. Diabetologia. 2002;45(7):S18-22.
17. Sharma P, Choudhry AA, Kumar P, Mahapatra T. Covid-19 and Diabetes Mellitus: A Life-Threatening Reciprocal Association. J Biochem Technol 2021;12(2):38-43.
18. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function and costs. Arch Intern Med. 2000;160(21):3278-85.
19. De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: meta-analysis. Psychosom Med. 2001;63(4):619-30.
20. Alqurashi MY, Alharthi KF, Abdulrahman A, Alshehri YK, Sanousi MA, Abdullah A, et al. The role of DPP-4 inhibitors in type-2 diabetes patients with chronic kidney disease. Pharmacophore. 2021;12(3):91-4.
21. Sadock BJ. Mood disorders. In: Kaplan HI, Sadock BJ, editors. Kaplan and Sadock's synopsis of psychiatry: behavioral sciences, clinical psychiatry. 8th ed. Baltimore, MD: Williams & Wilkins; 1998.
22. Ahmed NF, Alqahtani AS, Albalawi NM, Alanazi FK, Alharbi FM, Alsabah BA, et al. Diabetes in Adolescents and Children in Saudi Arabia: A Systematic review. Arch Pharm Pract. 2021;12(1):109-14.
23. Daulalas AD, Rallidis M. Association of depressive symptoms with coagulation factors in young, healthy individuals. Atherosclerosis. 2005;1(91):53-9.
24. Brownell KD, Cohen LR. Adherence to dietary regimens: An overview of research. Behav Med. 2002;20(4):54-149.
25. Ahmed AA, Alruwaili MN, Alanazi JF, Alanazi DF, Alanazi AS. Awareness of diabetic patients regarding diabetes complications in Saudi Arabia: systematic review. Pharmacophore. 2022;13(5):64-9.
26. Mohammadi M, Ghal-eriz P, Pahlevanzadeh S, Mosavei GA, Hamzeei M. Competitive prevalence incidence and severity of depression in diabetic patients treated by tablets and Insulin. Arak Med Univ J. 2001;14(4):25-9.
27. Kasper Dl, Braunwald M, Fauci AS, Hauser A. Harrison's principles of internal medicine. 16th Ed. New York: McGraw-Hill; 2005.
28. Grandinetti A, Kaholokula JK, Crabbek M, Kenui C, Chen R, Changh K. Relationship between depressive symptoms and diabetes among native Hawaiians. Psychoneuroendocrinology. 2000;25(3):239-46.
29. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069-78.
30. Abasalli Zadeh A, Asadollah AH. Answer to common patient's questions about depression. 1st ed; 2000. p. 13.
31. Gelder M. Oxford textbook of psychiatry. 3rd ed. Oxford: medical publication Psychiatry: 1995.
32. Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health. 2007;7(1):186.
33. Garduno-Espinosa J, Tellez-Zenteno JF, Hernandez-Ronquillo L. Frequency of depression in patients with diabetes mellitus type II. Rev Invest Clin. 1998;50(4):287.
34. Sevincok-L. Depression in a sample of Turkish type 2 diabetes patients, Turkey: Adnan Menderes. Eur Psychiatry. 2001;16(4):229-31.
35. Zahiroddin A, Sedighi G. Study of depression prevalence in diabetic patients referring to Emam Hosain and Loghman hospitals. Med Res. 2004;27:203-7. [In Persian]
36. Surwit RS, VanTilburg MA, Zucker N, McCaskill CC, Parekh P, Feinglos MN, et al. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care. 2002;25(1):30-4.
37. McGinnis RA, McGrady A, Cox SA, Grower-Dowling KA. Biofeedback- assisted relaxation in type 2 diabetes. Diabetes Care. 2005;28(9):2145-9.
38. Diabetes Week. Depression: Mental health treatment extends the lives of older patients with diabetes and depression. Atlanta; 2007. p. 10.
Copyright © 2024 - All Rights Reserved - Archives of Pharmacy Practice
Developed by Archives of Pharmacy Practice
